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*Escherichia coli* KRX is a commercially available derivate of *E. coli* K-12, created by Promega (catalog no. L3002 \[Madison, WI, USA\]). It combines characteristics that make it a suitable host for efficient plasmid transformation and propagation, as well as high-yield protein production with tight regulation. KRX is widely used for protein expression and protein evolution experiments, e.g., for cytochrome P450, peptide synthases, laccases, and Argonaute proteins ([@B1][@B2][@B4]), in certain cases showing markedly higher yields than other *E. coli* strains ([@B5]).

KRX enables high transformation efficiencies via the popular *recA1*, *endA1*, *hsdr17*, and *e14*^−^ gene alleles, preventing the degradation of plasmid DNA and unwanted recombination events ([@B6]).

Using the T7 RNA polymerase under control of the rhamnose-inducible promoter (*rha*P~BAD~), high protein yields can be achieved. *rha*P~BAD~ is activated by rhamnose and subjected to catabolite repression by glucose, enabling the use of autoinduction media. In *E. coli* KRX, the genes involved in the rhamnose metabolism have been deleted, ensuring a long induction phase.

While the genome of *E. coli* K-12 MG1655 is already publicly available ([@B7]), the genome of *E. coli* KRX shows some concise differences. Therefore, in this study, the draft genome sequence of *E. coli* KRX was established on the Illumina MiSeq system. A paired-end MiSeq sequencing run (2 × 300 bases) yielded 757,408 reads, accounting for 227.22 Mb of total sequence information. Assembly of all sequence reads applying the GS *De Novo* Assembler software (version 2.8) and reference mapping using r2cat ([@B8]) resulted in the draft sequences of the chromosome and the F plasmid of *E. coli* KRX, comprising 68 scaffolds and 110 contigs. Annotation of the chromosome was accomplished within the GenDB platform ([@B9]). The total size for the chromosome was determined to be 4,531,656 bp, featuring a G+C content of 50.78%. Gene prediction revealed 4,232 coding sequences (CDSs), 79 tRNA genes, and 5 rRNA genes. The F plasmid draft sequence has a size of 94,304 bp, features a G+C content of 48.01%, and contains 97 predicted protein-coding genes.

Analysis and interpretation of the *E. coli* KRX genome sequence within GenDB resulted in the identification of most described changes in comparison to *E. coli* K-12 MG1655. In contrast to the published genotype (\[F′ *traD36* Δ*ompP proA*^*+*^*B*^*+*^*lacIq* Δ(*lacZ*)M15\] Δ*ompT endA1 recA1 gyrA96* (*nal*^*r*^) *thi-1 hsdR17* (r~K~^−^ m~K~^*+*^) *e14*^−^ (*mcrA*^*--*^) *relA1 supE44* Δ(*lac-proAB*) Δ(*rha*~BAD~)::T7 RNA polymerase), no mutations in the *hsdR* and *relA* genes were detected. Interestingly, *E. coli* DH1 (GenBank accession no. CP001637), a strain that should harbor the same *hsdR17* and *relA1* alleles as KRX, also displays the native forms of these genes. This indicates that in a step leading to the creation of *E. coli* DH1 and *E. coli* KRX, these mutations were lost or incorrectly attributed. *E. coli* KRX contains a different mutation (Leu232Pro) instead of the one described in the literature for the *recA1* allele (Gly160Asp) ([@B6]). The genes *proA* and *proB* were located on the chromosome rather than on the F plasmid, potentially as a result of a reinsertion of these genes via homologous recombination.
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The *E. coli* KRX draft genome sequence was deposited in the EMBL database under the accession numbers [CYPX01000001](https://www.ncbi.nlm.nih.gov/nuccore/CYPX01000001) to [CYPX01000103](https://www.ncbi.nlm.nih.gov/nuccore/CYPX01000103).
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